Porcine serum albumin (PSA) is a globular protein found in the blood plasma of pigs (Sus scrofa domesticus). As a member of the albumin family, it is synthesized in the liver and constitutes approximately 50–60% of total plasma proteins in mammals . PSA shares structural and functional similarities with human serum albumin (HSA), including roles in maintaining colloid osmotic pressure, binding hydrophobic molecules (e.g., fatty acids, steroids), and transporting metals like zinc .
PSA is biosynthesized as preproalbumin in hepatocytes. Post-translational modifications include cleavage of signal peptides and disulfide bond formation . Commercial PSA is typically extracted from porcine serum via:
Heat Denaturation: Heating serum at 70°C with sodium caprylate to precipitate contaminants .
Chromatography: Anion-exchange or size-exclusion methods for purification (>99% purity) .
Colloid Osmotic Pressure: Contributes ~80% to plasma oncotic pressure .
Ligand Binding: Binds fatty acids, hormones (e.g., thyroxine), and drugs .
Antioxidant Activity: Scavenges reactive oxygen species (ROS) .
PSA exhibits cross-reactivity with cat serum albumin, triggering allergic reactions in sensitized individuals .
Clinical Impact: ~10% of cat-allergic patients develop pork allergies due to shared epitopes .
Plasma Expander: Polyoxazoline-conjugated PSA (POx-PSA) shows extended circulation half-life (15 hours vs. 7 hours for unmodified PSA) and reduced immunogenicity in animal models .
Allergen Detection: PSA serves as a biomarker for pork contamination in food via ELISA (detection limit: 1% pork in beef) .
Cell Culture: Enhances cell viability by reducing oxidative stress .
Metal Binding Studies: Used to investigate copper(II) and zinc transport mechanisms .
Marinating pork with protease-rich fruit juices (e.g., pineapple) reduces PSA levels by >90%:
Treatment | PSA Content (ng/mL) | Reduction vs. Control |
---|---|---|
Raw Pork | 95.4 | - |
Marinated (Pineapple) | 5.4 | 94% |
Marinated (Kiwi) | 14.3 | 85% |
Data from Kim et al. (2014) . |
POx-PSA demonstrates superior retention in vivo:
Circulation Half-Life: 15 hours (vs. 7 hours for native PSA) .
Immunogenicity: No anti-PSA IgG detected after repeated administration .
The protein has multiple functional domains that allow it to bind and transport various compounds in the bloodstream. This binding capacity is particularly important when considering PSA's role in research, as it affects both analytical approaches and therapeutic applications. PSA contains multiple binding sites with varying affinities for different ligands, making it highly versatile in transport functions .
The isolation and purification of high-quality PSA for research applications involves a multi-step process. The most effective methodology includes:
Collection of porcine blood, preferably from specific pathogen-free (SPF) swine to ensure quality and safety
Preparation of porcine plasma by removing cellular components
Addition of sodium caprylate to the plasma solution
Heat treatment at 70°C to denature contaminating proteins while preserving albumin
Removal of precipitated proteins by centrifugation
Purification of the supernatant using anion exchange chromatography (AEC)
Verification of purity using SDS-PAGE and size exclusion chromatography (SEC)
This procedure can yield PSA with approximately 99% purity, making it suitable for sensitive research applications. The quality of the starting material (porcine blood) significantly impacts the final product, which is why blood from SPF swine is preferred for applications requiring highly pure PSA .
PSA plays a dual role in biomarker discovery research. On one hand, it represents a challenge due to its high abundance, potentially masking less abundant proteins of interest. On the other hand, it serves as an important carrier protein that binds many potential biomarkers in blood. Research findings demonstrate that albumin is known to bind many proteins in the blood, thus potential biomarkers could be removed during albumin depletion procedures .
Studies using two-dimensional difference in gel electrophoresis (2D-DIGE) have demonstrated that whole serum containing PSA can be effectively used for biomarker discovery. The high resolution of modern analytical techniques permits the detection and quantification of substantial numbers of proteins even in the presence of abundant albumin. This approach preserves the complete protein profile, including albumin-bound proteins that might be potential biomarkers for livestock performance and health status .
PSA has emerged as a promising component in veterinary medicine, particularly as a base for artificial plasma expanders. Recent research has focused on polyoxazoline-conjugated PSA (POx-PSA) as an artificial plasma expander for dogs. This application addresses a critical need in veterinary medicine, as there is no adequate supply system for blood products despite growing demand for transfusion treatments in increasingly complex veterinary cases .
The primary purpose of administering albumin in veterinary contexts is to:
Maintain colloid osmotic pressure (COP)
Secure circulating blood volume
Address hypoalbuminemia resulting from various clinical conditions
POx-PSA has demonstrated complete resuscitation of hemorrhagic shock in animal models soon after injection. When administered to dogs intravenously, studies show no serum biochemical or hematological alterations and no overt deterioration of animal health, indicating good safety profile for veterinary use .
The impact of albumin depletion on porcine proteome analysis is significant and should be carefully considered when designing proteomic studies. Research findings using 2D-DIGE analysis have revealed:
Over 85% of protein spots resolved on at least half of the gels changed in abundance between whole and albumin-depleted sera
Of 204 protein spots significantly altered in abundance, 59 were changed over 400%
In depleted sera, 86 protein spots increased in abundance while 118 decreased
59.4% of protein spots in albumin-depleted samples had larger standard errors than in whole sera
These findings indicate that albumin removal alters the serum proteome in an unpredictable manner. While albumin removal methods are effective for porcine sera, they may introduce variability and potentially remove important biomarkers bound to albumin. Based on these results, researchers have proposed that whole serum can be used in gel-based proteomics systems for porcine biomarker identification without the need for albumin depletion .
Polyoxazoline (POx) conjugation significantly enhances the properties of PSA through several mechanisms. This polymer modification approach produces the following effects:
Extended circulation half-life: POx-PSA demonstrates a circulation half-life 2.1-fold longer than unconjugated PSA
Reduced immunogenicity: Rats produced neither anti-PSA IgG antibody nor anti-POx IgG antibody, suggesting excellent immunological stealth properties
Preserved function: The aqueous POx-PSA solution maintains moderately high colloid osmotic pressure and shows good blood cell compatibility
Improved stability: Lyophilized POx-PSA powder stored for 1 year can regenerate into a homogeneous solution without loss of function
The synthesis process involves creating unique POx bearing a sulfhydryl group terminus (POx-SH) through condensation with 3,3′-dithiodipropionic acid (DTDPA) followed by cleavage of the central disulfide bond. This modified POx is then conjugated to PSA. The resulting POx-PSA combines the beneficial properties of PSA with the biocompatibility and extended circulation offered by POx conjugation .
Several analytical techniques can be employed for the accurate quantification of PSA in biological samples, each with specific advantages:
Enzyme-Linked Immunosorbent Assay (ELISA)
Two-dimensional difference in gel electrophoresis (2D-DIGE)
Size Exclusion Chromatography (SEC)
The choice of method depends on the specific research context, sample complexity, required sensitivity, and available instrumentation.
Despite its potential benefits, several challenges must be addressed when developing PSA for therapeutic applications:
Immunogenicity: Native PSA can trigger immune responses when used across species, limiting its therapeutic utility. This challenge has been addressed through polymer conjugation strategies, with POx-PSA showing excellent immunological stealth properties .
Stability and shelf-life: Protein stability during storage is critical for therapeutic applications. Research demonstrates that lyophilization is an effective approach for PSA preparations, with studies showing that lyophilized POx-PSA powder maintains stability for at least one year .
Blood compatibility: For applications like plasma expanders, ensuring complete hemocompatibility is essential. POx-PSA has demonstrated good blood cell compatibility in research studies, making it promising for veterinary applications .
Production consistency: Obtaining consistently high-quality PSA for therapeutic use requires standardized purification protocols and rigorous quality control. Current methods using heat treatment (70°C) with sodium caprylate followed by anion exchange chromatography have achieved 99% purity .
POx-PSA has demonstrated significant potential as an artificial plasma expander, particularly for veterinary applications. Research findings show:
Complete resuscitation of hemorrhagic shock in rats was achieved soon after injection of POx-PSA solution
Serum biochemistry tests and histopathological observations indicated no abnormality in related organs
When administered to dogs intravenously:
These results address a critical need in veterinary medicine, where no adequate supply system exists for blood products despite growing demand for transfusion treatments. Traditional plasma expanders like hydroxyethyl starch (HES) and human serum albumin (HSA) have limitations in veterinary applications, making POx-PSA a promising alternative .
Research using 2D-DIGE analysis has revealed several advantages of using whole serum containing PSA for biomarker research compared to albumin-depleted samples:
Parameter | Whole Serum | Albumin-Depleted Samples |
---|---|---|
Protein profile integrity | Maintains complete profile including albumin-bound proteins | Altered profile with unpredictable changes in protein abundance |
Reproducibility | Lower standard error in 40.6% of protein spots | Higher standard error in 59.4% of protein spots |
Sample preparation | Simpler, fewer manipulation steps | More complex, additional processing required |
Risk of biomarker loss | Minimal risk | Potential loss of albumin-bound biomarkers |
Protein detection | Modern techniques allow detection despite albumin abundance | Improved detection of low-abundance proteins |
The research findings demonstrate that while albumin removal methods are effective, they significantly alter the serum proteome in ways that may compromise biomarker discovery. The resolution of albumin in 2D-DIGE analysis of whole sera now permits the detection and quantification of substantial numbers of proteins, making whole serum a viable option for porcine biomarker research .
Several emerging technologies show promise for expanding PSA applications:
Advanced polymer conjugation strategies beyond polyoxazoline, including biodegradable polymers that maintain PSA's extended half-life while allowing complete elimination
Site-specific modification technologies to control the location and degree of polymer attachment, preserving critical functional domains
Recombinant production systems for PSA to eliminate batch-to-batch variation and potential pathogen transmission
Computational approaches to predict binding properties and design PSA variants with enhanced carrier capabilities for drug delivery
Combination therapies utilizing PSA as both a plasma expander and a drug carrier simultaneously
These technologies could address current limitations and expand the utility of PSA in both research and therapeutic contexts, particularly for veterinary applications where blood product supply systems remain inadequate.
Advancements in proteomics methodologies are likely to further redefine approaches to PSA in biomarker discovery:
Improved resolution in separation techniques may further enhance detection of low-abundance proteins even in the presence of abundant albumin
Development of specific capture methods for PSA-bound proteins could enable targeted analysis of the albumin-bound proteome
Integration of multi-omics approaches could provide context for protein biomarkers by linking them to metabolic pathways
Machine learning algorithms applied to proteomic data may identify subtle patterns of protein changes that correlate with livestock performance
Miniaturized proteomic workflows could enable point-of-care testing using PSA-based biomarkers
These developments suggest that PSA will continue to play a dual role in biomarker discovery—both as a technical challenge to overcome and as a valuable carrier of potential biomarkers. The trend toward analyzing whole serum rather than depleting albumin is likely to continue as analytical techniques improve .